The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.00
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.50 (8.824%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 17.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 23rd Sep 2021 15:59

Friday 24 September 
Carnival PLCQ3 Results
Dunedin Enterprise Investment Trust PLCHalf Year Results
Judges Scientific PLCHalf Year Results
Monday 27 September 
Beeks Financial Cloud Group PLCFull Year Results
FireAngel Safety Technology GroupHalf Year Results
i3 Energy PLCHalf Year Results
Instem PLCHalf Year Results
Medica Group PLCHalf Year Results
Microsaic Systems PLCHalf Year Results
Minds + Machines Group LtdHalf Year Results
Oxford Cannabinoid Technologies Holdings PLCFull Year Results
United Utilities Group PLCTrading Statement
Tuesday 28 September 
AG Barr PLCHalf Year Results
Animalcare Group PLCHalf Year Results
Blancco Technology Group PLCFull Year Results
Brand Architekts Group PLCFull Year Results
Card Factory PLCHalf Year Results
Close Brothers Group PLCFull Year Results
Digitalbox PLCHalf Year Results
Ergomed PLCHalf Year Results
Escape Hunt PLCHalf Year Results
Ferguson PLCFull Year Results
HeiQ PLCHalf Year Results
Hotel Chocolat Group PLCFull Year Results
Immotion Group PLCHalf Year Results
Itaconix PLCHalf Year Results
Lords Group Trading PLCHalf Year Results
Moonpig Group PLCTrading Statement
Mortgage Advice Bureau Holdings PLCHalf Year Results
Next Fifteen Communications Group PLCHalf Year Results
Northcoders Group PLCHalf Year Results
Pennon Group PLCTrading Statement
S&U plcHalf Year Results
Serica Energy PLCHalf Year Results
Smiths Group PLCFull Year Results
SourceBio International PLCHalf Year Results
Transense Technologies PLCFull Year Results
Yourgene Health PLCTrading Statement
Wednesday 29 September 
1Spatial PLCHalf Year Results
Allied Minds PLCHalf Year Results
Cap-XX LtdFull Year Results
CMO Group PLCHalf Year Results
Futura Medical PLCHalf Year Results
Glantus Holdings PLCHalf Year Results
MyCelx Technologies CorpHalf Year Results
MyHealthChecked PLCHalf Year Results
NetScientific PLCHalf Year Results
Next PLCHalf Year Results
Origin Enterprises PLCFull Year Results
Quiz PLCFull Year Results
SEEEN PLCHalf Year Results
SSE PLCTrading Statement
SSP Group PLCTrading Statement
Sumo Group PLCHalf Year Results
Yu Group PLCHalf Year Results
Thursday 30 September 
Angle PLCHalf Year Results
Avacta Group PLCHalf Year Results
Boohoo Group PLCHalf Year Results
Ceres Power Holdings PLCHalf Year Results
Go-Ahead Group PLCFull Year Results
Physiomics PLCFull Year Results
Power Metal Resources PLCTrading Statement
Renishaw PLCFull Year Results
Rockhopper Exploration PLCHalf Year Results
Synairgen PLCHalf Year Results
WANdisco PLCHalf Year Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Aug 2020 12:41

Angle's Parsortix Able To Predict Patients' Response To Treatment

Angle's Parsortix Able To Predict Patients' Response To Treatment

Read more
20 Jul 2020 20:03

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

Read more
20 Jul 2020 10:16

Angle's 'Parsortix' advantageous in breast cancer in new research

(Sharecast News) - Angle announced on Monday that the University of Southern California (USC) has published peer-reviewed results of new work undertaken in metastatic breast cancer (MBC), highlighting advantages of a 'Parsortix' liquid biopsy, compared to standard-of-care tissue biopsy.

Read more
25 Jun 2020 12:22

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Read more
18 Jun 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
10 Jun 2020 16:41

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

Read more
12 May 2020 18:54

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Read more
12 May 2020 08:58

Angle upbeat on recent research using 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the liquid biopsy analysis unit at the Health Research Institute of Santiago in Spain has published results of new work undertaken in head and neck cancer and non small cell lung cancer, on the potential utility of a liquid biopsy-based strategy to assess MET alterations on circulating tumour cells (CTCs).

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
28 Apr 2020 10:03

Angle works with skeleton R&D crew during lockdown

(Sharecast News) - Biopharmaceuticals group Angle said on Tuesday that progress had been impeded by the Covid-19 outbreak as the firm worked with a research and development skeleton crew in Guildford.

Read more
31 Mar 2020 12:21

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

Read more
31 Mar 2020 09:40

Angle UK, US, Canada operations 'severely disrupted' by Covid-19

(Sharecast News) - Liquid biopsy company Angle said on Tuesday that operations in the UK, US and Canada had all been "severely disrupted" by the Covid-19 pandemic.

Read more
3 Mar 2020 18:58

Angle Parsortix Test Used To Help Discover Brain Metastasis

Angle Parsortix Test Used To Help Discover Brain Metastasis

Read more
27 Feb 2020 14:09

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Read more
27 Feb 2020 12:42

Angle upbeat on recent Parsortix research out of Italy

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that Istituto Nazionale Tumori di Milano in Milan, Italy, has published results of work assessing the performance of its 'Parsortix' system in renal cell carcinoma (RCC), demonstrating key advantages of Parsortix.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.